Secukinumab for the treatment of SAM syndrome associated with desmoglein‐1 deficiency
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
British journal of dermatology. - 184, 4 (2021) , 770-772, ISSN: 1365-2133
- Ereignis
-
Veröffentlichung
- (wo)
-
Freiburg
- (wer)
-
Universität
- (wann)
-
2021
- Urheber
- DOI
-
10.1111/bjd.19684
- URN
-
urn:nbn:de:bsz:25-freidok-1748637
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
2025-08-14T10:55:14+0200
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Frommherz, Leonie
- Schempp, Christoph Mathis
- Has, Cristina
- Universität
Entstanden
- 2021
Ähnliche Objekte (12)
Dupilumab bessert kongenitale Ichthyose : = Dupilumab improves congenital ichthyosis
Advances in understanding the molecular basis of skin fragility
Dupilumab improves congenital ichthyosis
Strategy for the optimization of read-through therapy for junctional epidermolysis bullosa with COL17A1 nonsense mutation
Ausgewählte Genodermatosen – Stand der Dinge und Zukunftsaussichten
Update on genetic conditions affecting the skin and the kidneys
Selected genodermatoses – Status quo and future prospects
Molecular therapeutics in development for Epidermolysis bullosa: update 2020
Treatment of epidermolysis bullosa and future directions: a review
Dupilumab improves itch and blistering in different subtypes of epidermolysis bullosa
Kindler syndrome in a patient with colitis and primary sclerosing cholangitis : : coincidence or association?
Junctional epidermolysis bullosa: allelic heterogeneity and mutation stratification for precision medicine
Dupilumab bessert kongenitale Ichthyose : = Dupilumab improves congenital ichthyosis
Advances in understanding the molecular basis of skin fragility
Dupilumab improves congenital ichthyosis
Strategy for the optimization of read-through therapy for junctional epidermolysis bullosa with COL17A1 nonsense mutation
Ausgewählte Genodermatosen – Stand der Dinge und Zukunftsaussichten
Update on genetic conditions affecting the skin and the kidneys
Selected genodermatoses – Status quo and future prospects
Molecular therapeutics in development for Epidermolysis bullosa: update 2020
Treatment of epidermolysis bullosa and future directions: a review
Dupilumab improves itch and blistering in different subtypes of epidermolysis bullosa
Kindler syndrome in a patient with colitis and primary sclerosing cholangitis : : coincidence or association?
Junctional epidermolysis bullosa: allelic heterogeneity and mutation stratification for precision medicine
Dupilumab bessert kongenitale Ichthyose : = Dupilumab improves congenital ichthyosis
Advances in understanding the molecular basis of skin fragility
Dupilumab improves congenital ichthyosis
Strategy for the optimization of read-through therapy for junctional epidermolysis bullosa with COL17A1 nonsense mutation
Ausgewählte Genodermatosen – Stand der Dinge und Zukunftsaussichten
Update on genetic conditions affecting the skin and the kidneys
Selected genodermatoses – Status quo and future prospects
Molecular therapeutics in development for Epidermolysis bullosa: update 2020
Treatment of epidermolysis bullosa and future directions: a review
Dupilumab improves itch and blistering in different subtypes of epidermolysis bullosa
Kindler syndrome in a patient with colitis and primary sclerosing cholangitis : : coincidence or association?